Dr. Stevens earned her BS in Biochemistry at UC Davis, and then her MD and PhD at Baylor College of Medicine, where she studied the mechanisms of hormonal regulation of T lymphocyte activation. She completed a residency in pediatrics at Children’s Hospital Medical Center in Cincinnati and a fellowship in pediatric rheumatology at the University of Washington. She is board-certified in Pediatrics and Pediatric Rheumatology.
She has served as the Pediatric Rheumatology Division Chief and Professor at the University of Washington and as a principal investigator in the Seattle Children’s Research Institute Center for Immunity and Immunotherapies, with a focus on lymphocyte regulation in lupus and scleroderma. She served as an attending physician at Seattle Children’s Hospital. As Chair of the American Board of Pediatrics Rheumatology Subboard and the ACR Annual Meeting Pediatrics Planning Committee, she worked to establish evidenced-based medicine as the benchmark for caring for children with immune-mediated disease and the roadmap for research.
Dr. Stevens continues her research focused on understanding lymphocyte regulation with the goal of developing novel treatments for patients suffering with immune-mediated diseases in her role as Executive Clinical Director at Acelyrin.